General
Preferred name
FUROSEMIDE
Synonyms
Lasix ()
Furosemid ()
Furanthril ()
Furosemide (sodium) ()
Furosemide (NSC 269420) ()
Furosemide sodium ()
NSC 269420 ()
Lasix, Frusemide Sodium ()
Mirfat ()
Frusid ()
Dryptal ()
Frusetic ()
Oedemex ()
Aquamed ()
Furosemidum ()
Frusemide ()
Aluzine 500 ()
Rusyde ()
Logirene ()
Froop ()
Hydroled ()
Frusol ()
Aluzine 20 ()
Frumil ()
Frumax ()
Lasix Ret ()
Diuresal ()
Tenkofruse ()
LB-502 ()
Marsemide ()
Disal ()
NSC-269420 ()
Aluzine 40 ()
Furosemide-d5 ()
P&D ID
PD002324
CAS
54-31-9
41733-55-5
106391-48-4
1189482-35-6
Tags
natural product
drug
available
Approved by
FDA
First approval
1966
Drug Status
approved
vet_approved
Drug indication
Congestive heart failure
Diuretic
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Furosemide is a loop diuretic drug. (GtoPdb)
DESCRIPTION Ligand of the translocator protein (TSPO); also GABAA receptor potentiator (Tocris Bioactive Compound Library)
DESCRIPTION Na+/2Cl-/K+ (NKCC) symporter inhibitor. Also antagonizes GABAA (Tocriscreen Plus)
Cell lines
0
Organisms
2
Compound Sets
32
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
62
Properties
(calculated by RDKit )
Molecular Weight
330.01
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
2
cLogP
1.89
TPSA
122.63
Fraction CSP3
0.08
Chiral centers
0.0
Largest ring
6.0
QED
0.77
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Transporters
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
Na-K-Cl cotransporter
CA2, GPR35, SLC12A1, SLC12A2
GABA Receptor
NKCC
GABA Receptor,NKCC
Primary Target
Na+/K+/Cl- Symporter
MOA
Inhibitor
Antidiuretic
diuretic
Member status
virtual
Indication
edema, hypertension, congestive heart failure, nephrotic syndrome
Disease Area
cardiology, rheumatology
Therapeutic Class
Diuretics
Source data